Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Solid Tumor × Anastrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Breast 1

Conditions

Breast Neoplasms 6 Solid Tumor 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1

Interventions

vistusertib 2 toripalimab 1 tanespimycin 1 sargramostim 1 roniciclib 1 abemaciclib 1 Letrozole 1 Ipilimumab 1 Hydroxychloroquine 1 Fulvestrant 1 Anastrozole 1 Albumin-Bound Paclitaxel 1 AMG 337 1 4-toluenesulfonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04316169 2022-12-23

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Medical College of Wisconsin

Phase 1 Withdrawn

BreastOther solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡